tirzepatide fda news says shortage of GLP-1 drug is over Tirzepatide drug fast-tracked for weight
Description
It is manufactured by Novo Nordisk and is available under two primary brand names: Ozempic FDA-approved for type 2 diabetes management Wegovy FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity Semaglutide is administered as a once-weekly subcutaneous injection, making it one of the most convenient weight loss medications in terms of dosing frequency

However, their combination may increase the risk of drowsiness, dizziness, or seizures

Strength sports, including Olympic weightlifting, powerlifting, Hyrox, and CrossFit

We dont have that track record in teens or really even adults yet. Better scientific understanding is only part of the equation, though

How Americans view weight-loss drugs and their potential impact on obesity in the U.S